List of Excipients in API dorzolamide hydrochloride and timolol maleate preservative free
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing dorzolamide hydrochloride and timolol maleate preservative free
Detailed excipient profiles for dorzolamide hydrochloride and timolol maleate preservative free
Excipient focus: HYDROXYETHYL CELLULOSE
dorzolamide hydrochloride and timolol maleate preservative free drug variants containing HYDROXYETHYL CELLULOSE
dorzolamide hydrochloride and timolol maleate preservative free drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
dorzolamide hydrochloride and timolol maleate preservative free drug variants containing MANNITOL
dorzolamide hydrochloride and timolol maleate preservative free drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
dorzolamide hydrochloride and timolol maleate preservative free drug variants containing SODIUM HYDROXIDE
dorzolamide hydrochloride and timolol maleate preservative free drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
dorzolamide hydrochloride and timolol maleate preservative free drug variants containing TRISODIUM CITRATE DIHYDRATE
dorzolamide hydrochloride and timolol maleate preservative free drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
dorzolamide hydrochloride and timolol maleate preservative free drug variants containing WATER
dorzolamide hydrochloride and timolol maleate preservative free drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch